Table1.
Characteristics of breast cancer patient included in this study
| Mean±SD of variable | Number (%) |
|---|---|
| Age (years) 51.512.2 | 58 (100) |
| BMI( kg/m2) 29.3 5.0 | 58 (100) |
| Clinical Stage | |
| Stage I Stage II Stage III Stage IV |
4 (6.9) 29 (50.0) 21 (36.2) 4 (6.9) |
| Estrogen and Progesterone receptor | |
| Positive Negative |
38 (65.5) 20 (34.5) |
| Her-2 | |
| Positive Negative |
9 (15.5) 49 (84.5) |
| Histology type | |
| IDC ILC |
54 (93.1) 4 (6.9) |
| Lymph node involvement | |
| N0 N1 N2 N3 |
16 (27.6) 20 (34.5) 16 (27.5) 6 (10.4) |
Age and BMI are expressed as mean ± standard deviation (SD); BMI was calculated as weight/height2 (kg/m2); Her-2: human epidermal growth factor receptor; IDC: invasive ductal carcinoma; ILC: invasive lobular carcinoma